196 postdoc-in-distributed-systems-and-controls Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
Listed
-
Field
-
A one-year Research Assistant position is available in Prof Ivan Ahel’s group based in the Sir William Dunn School of Pathology, University of Oxford to study ADP-ribosylation signalling in DNA
-
of the expansion is to reduce the frequency of collisions, so that chemical and thermal relaxation processes are slowed down. There are indications that commonly accepted rate constants for non-equilibrium
-
Applications are invited for a Postdoctoral Research Assistant in Ion Trap Quantum Computing. The post is available initially for a fixed-term duration of 3 years, with the possibility of extension
-
on understanding the spread and control of human infectious diseases using modelling and pathogen genomics. This is a short-term opportunity to apply machine learning methods to two key projects. First, you will
-
A postdoctoral position is available in Prof. Ivan Ahel’s group based in the Sir William Dunn School of Pathology, University of Oxford to study the interplay of ADP-ribosylation and ubiquitylation
-
The Department of Biology is seeking to recruit a Postdoctoral Research Associate for 6 months (ending no later than 18th April 2026 currently). This post is financially supported by funds from a
-
biochemical reconstitution, electron cryomicroscopy (cryo-EM), advanced bacterial genetics, and phage biology to explore how cells and viruses control the three-dimensional structure of DNA. We investigate how
-
179911 – Postdoctoral Research Assistant Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Grade 7: £38,674 per annum This is a full time, fixed term position
-
incorporated into cellular function. We are now looking for a postdoc with expertise in IDPs and NMR that can help us study these systems in more detail. Training will be provided in NMR, programming methods
-
an industry partnered project for translational drug discovery. The role will involve analysing large scale omics and spatial datasets from both primary patient samples and advanced in vitro model systems